Ep. 12: How IBD Called The Correction – And Where It May Go With Chris Gessel

This week, IBD Chief Content Officer Chris Gessel joined the podcast to discuss "vertical violations," which can be used to spot prolonged sell-offs. We also look at three stocks that are bucking the downtrend: Repligen, Anaplan and Insulet. Plus, Randy Watts of William O'Neil + Co. returns for a sponsored interview with Doug Peebles, Chief Investment Officer of Fixed Income at AllianceBernstein, about fixed income strategies. For the video version, show notes and charts, go to investors.com/podcast. Learn more about your ad choices. Visit megaphone.fm/adchoices